-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Arcus Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2019 to Q3 2025.
- Arcus Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 107M shares, a 16.5% increase year-over-year.
- Arcus Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 90.1M shares, a 21.8% increase from 2023.
- Arcus Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 74M shares, a 2.78% increase from 2022.
- Arcus Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 72M shares, a 2.7% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)